Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case

Poteshkina N.G.; Khashieva F.M.

doi:https://doi.org/10.17116/terarkh2014861281-84

Poteshkina N.G.

GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova" Minzdrava Rossii, Moskva;
GBUZ "Gorodskaia klinicheskaia bol'nitsa #52 Departamenta zdravookhraneniia goroda Moskvy", Moskva

Khashieva F.M.

Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case

Authors:

Poteshkina N.G., Khashieva F.M.

More about the authors

Journal: Therapeutic Archive. 2014;86(12): 81‑84

DOI: 10.17116/terarkh2014861281-84

Read: 1388 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Poteshkina NG, Khashieva FM. Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case. Therapeutic Archive. 2014;86(12):81‑84. (In Russ.)
https://doi.org/10.17116/terarkh2014861281-84

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medicine. 2024;(11):141-146

Predictors of Engagement and Active participation of Patients with Uncontrolled Hypertension in the Telehealth Surveillance Program. Russian Journal of Preventive Medicine. 2024;(12):37-43

Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers. Russian Cardiology Bulletin. 2024;(4-2):161-171

Risk factors and adverse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medicine. 2025;(2):31-37

Diagnostics of hypertensive disorders in cardio-obstetrics: current state-of-affairs. Russian Journal of Human Reproduction. 2025;(1):63-77

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Visceral obesity is a reversible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16

Features of the interpretation of bodily sensations by patients with arterial hypertension. Russian Journal of Preventive Medicine. 2025;(10):82-87

Study of the effectiveness of the drug Elcarnitine in the correction of increased variability of arterial pressure in patients with hypertensive disease and cognitive dysfunction. Russian Journal of Preventive Medicine. 2025;(10):88-92

Abstract:

The paper describes a clinical case of the efficacy of a fixed-dose combination of perindopril and amlodipine used in a hypertensive patient. It shows its clinical effectiveness with no impact on blood lipid and glucose levels. 24-hour blood pressure monitoring revealed a reduction in daily blood pressure, including its variability, in pulse wave propagation velocity and central aortic pressure.

Keywords:

hypertension

angiotensin-converting enzyme

potassium antagonists

Authors:

Poteshkina N.G.

Khashieva F.M.

Close metadata

References:

The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J doi:10.1093/eurheartj/eht151.
Тронина О.А., Гендлин Г.Е., Сторожаков Г.И. Optimal'naya strategiya lecheniya AG - fiksirovannaya kombinirovannaya terapiya. Sovremennye aspekty ispol'zovaniya. Med zhurn on-line 2008; 2: 22 marta.
Gupta A.K., Arshad S., Poulter N.R. Compliance, safety, and effectiveness of fixed-dos combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55 (2): 399-407.
Sever P.S., Dahlof B., Poulter N.R. et al.; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895.
Карпов Ю.А., Горбунов В.М., Деев А.Д. PRORYV 2. Vliyanie fiksirovannoi kombinatsii perindoprila i amlodipina na arterial'noe davlenie, izmerennoe v kabinete vracha, s pomoshch'yu sutochnogo monitorirovaniya i samokontrolya, u patsientov s nekontroliruemoi arterial'noi gipertoniei. AtmosferA. Novosti kardiol 2014; 1: 1-6.
Nagy V. 24 hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed dose combination (PEARL-ABPM study). J Hypertens 2011; 29 e-supplement A: e280.
Rothwell P.M., Howard S.C., Dolan E. et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure and episodic hypertension. Lancet 2010; 375: 895-905.
Кобалава Ж.Д., Котовская Ю.В., Троицкая Е.А. и др. Vliyanie fiksirovannoi kombinatsii perindoprila i amlodipina na mezh- i vnutrivizitnuyu variabel'nost' arterial'nogo davleniya i chastoty serdechnykh sokrashchenii v real'noi klinicheskoi praktike v Rossiiskoi nablyudatel'noi programme KONSTANTA. Kardiologiya 2014; 1: 34-40.
Scuteri A., Tesauro M., Appolloni S. et al. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 2007; 25: 1035-1040.
Hulsen H.T., Nijdam M.E., Bos W.J. et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens 2006; 24: 1027-1032.
Williams B., Lacy P.S., Thom S.M. et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.